Chimeric Antigen Receptor News and Research

RSS
Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

Innovative immunotherapy targets rare melanoma subtypes

Innovative immunotherapy targets rare melanoma subtypes

City of Hope cures oldest person of blood cancer and achieves HIV remission

City of Hope cures oldest person of blood cancer and achieves HIV remission

Study finds interleukin-24 enhances CAR-T cell therapy's effectiveness against cancer stem cells

Study finds interleukin-24 enhances CAR-T cell therapy's effectiveness against cancer stem cells

Novel approach improves CAR T-cell therapy efficacy against acute myeloid leukemia

Novel approach improves CAR T-cell therapy efficacy against acute myeloid leukemia

Scientists develop safer CAR T-cell strategy for treating lymphomas

Scientists develop safer CAR T-cell strategy for treating lymphomas

CAR T cells target senescent cells, improve healthspan in mice

CAR T cells target senescent cells, improve healthspan in mice

CRISPR revolutionized: New method edits genes directly in the body

CRISPR revolutionized: New method edits genes directly in the body

Asimov launches LV Edge Packaging System to optimize lentivirus production

Asimov launches LV Edge Packaging System to optimize lentivirus production

Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024

Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024

Revolutionary CAR T-cell therapy shows promise in reversing age-related metabolic dysfunction

Revolutionary CAR T-cell therapy shows promise in reversing age-related metabolic dysfunction

T cells can be reprogrammed to fight aging

T cells can be reprogrammed to fight aging

New workflow identifies shared cancer targets, advancing immunotherapy

New workflow identifies shared cancer targets, advancing immunotherapy

Cord blood-derived CAR NK cell therapy targeting CD19 shows promise for treating patients with B-cell malignancies

Cord blood-derived CAR NK cell therapy targeting CD19 shows promise for treating patients with B-cell malignancies

Decoding blood cancer secrets to optimize CAR T therapy

Decoding blood cancer secrets to optimize CAR T therapy

Double punch for B-cell lymphomas: CAR T-cell innovation boosts efficacy, cuts toxicity

Double punch for B-cell lymphomas: CAR T-cell innovation boosts efficacy, cuts toxicity

CAR-T cell therapy remains viable for patients in lymphoma remission, study finds

CAR-T cell therapy remains viable for patients in lymphoma remission, study finds

Phase I clinical trial of new CAR T cell therapy AT101 shows promising early responses

Phase I clinical trial of new CAR T cell therapy AT101 shows promising early responses